Literature DB >> 8616695

Plasmin, fibrin degradation and angiogenesis.

W D Thompson, C M Stirk, W T Melvin, E B Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8616695     DOI： 10.1038/nm0596-493

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.

Authors:  Lakshmi Venkatraman; Huipeng Li; C Forbes Dewey; Jacob K White; Sourav S Bhowmick; Hanry Yu; Lisa Tucker-Kellogg
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

2.  Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.

Authors:  Hajime Fujimoto; Esteban C Gabazza; Osamu Taguchi; Yoichi Nishii; Hiroki Nakahara; Nelson E Bruno; Corina N D'Alessandro-Gabazza; Michael Kasper; Yutaka Yano; Mariko Nagashima; John Morser; George J Broze; Koji Suzuki; Yukihiko Adachi
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 3.  The regulatory function of SPARC in vascular biology.

Authors:  Lee B Rivera; Amy D Bradshaw; Rolf A Brekken
Journal:  Cell Mol Life Sci       Date:  2011-08-06       Impact factor: 9.261

4.  Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors.

Authors:  A Arkudas; J Tjiawi; A Saumweber; J P Beier; E Polykandriotis; O Bleiziffer; R E Horch; U Kneser
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.